financetom
Business
financetom
/
Business
/
Mars prices $26 billion 8-part bond, highlights big M&A financing week
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mars prices $26 billion 8-part bond, highlights big M&A financing week
Mar 5, 2025 5:01 PM

*

Mars issues 8-part bond for Kellanova ( K ) acquisition

*

Bond offering to raise $26 billion, bookrunners say

*

Mars bond deal may more than double M&A bond issuance for

2025,

IGM reports

(Changes sourcing throughout)

By Shankar Ramakrishnan

March 5 (Reuters) - Family-owned candy giant Mars on

Wednesday priced a $26 billion eight-part investment-grade bond

offering to help finance its takeover of Pringles maker

Kellanova ( K ), in what is expected to be one of the largest

acquisition financing deals this year.

Bank of America ( BAC ), BNP Paribas, Citigroup ( C/PN )

, JP Morgan, Morgan Stanley ( MS ) and Rabobank

were the bookrunners for the offering.

Reuters last week reported the bonds would be announced this

week.

Mars priced bonds with maturities ranging from two years to

40 years, and said it will redeem the notes at a price of 101%

of the principal amount if the acquisition was not completed by

August 20, 2026, it said in a statement.

The bonds headlined what has been a heavy week for

acquisition financing. On Monday, design software maker Synopsys ( SNPS )

raised $10 billion selling six tranches of bonds that

had maturities from two years to 30, to help finance its $34

billion takeover of Ansys.

Demand for Synopsys ( SNPS ) bonds was massive with books covered

some three to five times the issuance size, according to Informa

Global Markets data.

If Mars raises $25 billion, it would become the

eighth-largest deal of all time and more than double the amount

of M&A-related investment-grade bond issuance for the year, said

IGM.

The announcement of the bond was made on a day when markets

were relatively stable after a selloff earlier in the weekm as

U.S. President Trump escalated a global trade war on Tuesday by

imposing 25% tariffs on top trade partners, Canada and Mexico,

citing ineffective border controls.

(Reporting by Shankar Ramakrishnan, Additional reporting by

Chandni Shah; Editing by Nick Zieminski and Varun H K)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Health insurers slide after Trump targets Obamacare subsidies
Health insurers slide after Trump targets Obamacare subsidies
Nov 10, 2025
(Reuters) -Shares of health insurers with plans under the Affordable Care Act, or Obamacare, fell 7% to 1.5% premarket on Monday after U.S. President Donald Trump said federal funds subsidizing those plans must be redirected to Americans buying coverage. The subsidies, which are due to expire at the end of the year, were introduced during the COVID-19 pandemic to help...
Priority Technology Holdings, Inc. Board Confirms Receipt of Preliminary, Non-Binding Take Private Proposal
Priority Technology Holdings, Inc. Board Confirms Receipt of Preliminary, Non-Binding Take Private Proposal
Nov 10, 2025
ALPHARETTA, Ga.--(BUSINESS WIRE)-- Priority Technology Holdings, Inc. ( PRTH ) (“Priority” or the “Company”) announced today that it has received a preliminary, non-binding proposal (the “Proposal”) from an investor group led by Thomas Priore, the Company’s Chairman and Chief Executive Officer (the “Investor Group”), to acquire the remaining shares of the Company’s common stock that the Investor Group does not...
Metsera falls after accepting up to $10 billion sweetened buyout offer from Pfizer
Metsera falls after accepting up to $10 billion sweetened buyout offer from Pfizer
Nov 10, 2025
(Reuters) -Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a sweetened offer from Pfizer to end a fierce bidding war between the pharma giant and Danish rival Novo Nordisk. U.S. drugmaker Pfizer said late on Friday it had clinched a $10 billion deal for Metsera, in a blow to Novo as...
Health insurers slide after Trump targets Obamacare subsidies
Health insurers slide after Trump targets Obamacare subsidies
Nov 10, 2025
(Reuters) -Shares of health insurers with plans under the Affordable Care Act, or Obamacare, fell 7% to 1.5% premarket on Monday after U.S. President Donald Trump said federal funds subsidizing those plans must be redirected to Americans buying coverage. The subsidies, which are due to expire at the end of the year, were introduced during the COVID-19 pandemic to help...
Copyright 2023-2026 - www.financetom.com All Rights Reserved